Cipla USA recalls Lanreotide Injection 120 mg/0.5 mL syringes due to particulate matter. Affected lots expire through 2027. Stop using if you have these specific lot numbers.
“Cipla Lanreotide Injection Recall: Particulate Matter Hazard.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31559-cipla-lanreotide-injection-recall-particulate-matter-hazard. Based on FDA recall #D-0290-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0290-2026%22&limit=1).
The FDA announced on Jan. 2, 2026, that Cipla USA, Inc. is voluntarily recalling Lanreotide Injection due to the presence of particulate matter. The recall affects 15,221 pre-filled syringes distributed nationwide.
The recall is due to the presence of particulate matter in the injection. The FDA classifies this as a Class II recall.
Context
GovInfoNow's records show Cipla USA, Inc. has 12 other recalls on record since June 27, 2023. Other recent recalls of similar products include Lupin Liraglutide 18mg/3mL Injection Recall (April 24, 2026), B. Braun Medical Lactated Ringer's Injection Recall (Aug. 12, 2026), and Sunny Pharmtech Cyclophosphamide Injection Recall (July 17, 2026).
How to tell if you have this one
Check the lot number on the syringe label. Affected lots include 4301954IR1 through 4401023IR1, expiring through March 2027.
Brand
Cipla
Category
Drug
Based on the official FDA remedy
What to do — step by step
Stop Using Immediately
Discard any Lanreotide Injection syringes with the affected lot numbers listed in the recall.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 19 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0290-2026 (January 2, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0290-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.